MORE ON DR. POLASCIK
Memberships

• Fellow, American College of Surgeons
• American Urological Association
• American Medical Association
• Society of Urologic Oncology
• Southeastern section AUA
• North Carolina Urological Association
• North Carolina Chapter, American College of Surgeons
• North Carolina Medical Society
• Society for Cryobiology
• American College of Surgeons Professional Association
• Society of Laparoendoscopic Surgeons
• The Johns Hopkins Medical and Surgical Association
• Phi Beta Kappa, 1986
• Alpha Sigma Nu National Jesuit Honor Society, 1986

• "The complications associated with partial nephrectomy for tumor." Podium session. Mid-Atlantic section 52nd annual meeting, October 1994, Philadelphia.
• "Partial nephrectomy: technique, complications and pathological findings." Podium session. Annual Maryland Urological Association, December 1994, Baltimore.
• "Frequent loss of heterozygosity on chromosome arms 8p and 13q in collecting duct carcinoma of the kidney." Poster session: kidney neoplasms-basic III. AUA 90th annual meeting, April 1995, Las Vegas. Best poster award.
• "Intraoperative sonography for the evaluation and management of renal tumors: experience with 100 patients." Podium session: kidney neoplasms-clinical II. AUA 90th annual meeting, April 1995, Las Vegas.
• "Partial nephrectomy: technique, complications and pathological findings." Podium session: kidney neoplasms-clinical II. AUA 90th annual meeting, April 1995, Las Vegas.
• "Microsatellite allelotype of chromosome 4 in human invasive bladder carcinoma." Podium session: bladder cancer-molecular markers and prognosis. AUA 90th annual meeting, April 1995, Las Vegas.
• "Reappraisal of the role of human chorionic gonadotropin for the diagnosis and treatment of the nonpalpable testis: a 10-year experience." Podium session.
  Am Acad Pediatrics, Section of Urology, October 1995, San Francisco.
  Annual Maryland Urological Association, December 1995, Baltimore.
• "Distal nephron renal tumors: microsatellite allelotype." Poster session. AUA 91th annual meeting, May 1996, Orlando, FL.
• "Intraoperative ultrasound for renal tumors: its importance in partial nephrectomy." Podium session. Mid-Atlantic section 54th annual meeting, October 1996, Washington DC.
• "Long-term survival after radical nephrectomy with intrahepatic or supra-diaphragmatic intracaval thrombectomy for renal cell carcinoma." Podium session: kidney neoplasms - clinical. AUA 92nd annual meeting, April 1997, New Orleans.
• "Intraoperative color Doppler and power Doppler sonography: improved technical advantages with partial nephrectomy for renal tumors." Podium session: kidney neoplasms - clinical. AUA 92nd annual meeting, April 1997, New Orleans.
• "Long-term survival after radical nephrectomy with intrahepatic or supradiaphragmatic intracaval thrombectomy for renal cell carcinoma." Oral session: kidney cancer. SIU 24th Congress, September 1997, Montreal, Canada.
• "The use of percent free prostate-specific antigen for staging of men with clinically localized prostate cancer." Oral session: prostate cancer. Mid Atlantic section 55th annual meeting, September 1997, Hot Springs, Virginia.
• "Comparison of staging algorithms and a monoclonal antibody scan (ProstaScint) to predict lymph node involvement in high-risk prostate cancer." Poster session: staging and prognosis. AUA 93rd annual meeting, June 1998, San Diego.
• "Harvest of intact prostate cancer cells from blood: Further characterization of a new assay." Poster session: prostate cancer, basic research. AUA 93rd annual meeting, June 1998, San Diego.
• "Lack of cadherin-6 expression is correlated with disease progression in clear cell renal cell carcinoma." Poster session: kidney cancer, research. AUA 93rd annual meeting, June 1998, San Diego.
• "Ablation of renal tumors in a rabbit model with interstitial saline augmented radiofrequency energy: Preliminary report of a new technology." Poster session, 16th World Congress on Endourology and SWL, Sept 3, 1998, New York.
• “Laparoscopic repair of retrocaval ureter.” Video session, Southeastern AUA, March 1999, Charleston.
• “Ablation of renal tumors in a rabbit model with interstitial saline augmented radiofrequency energy: Preliminary report of a new technology.” Poster session, AUA 94th annual meeting, May 1999, Dallas.
• "Survey of neuromuscular injuries to the patient and surgeon during urologic laparoscopic surgery." Poster session, 17th World Congress on Endourology, September 1999, Rhodes, Greece.
• “p27 staining of circulating prostate cancer cells does not correlate with pathologic stage.” Poster session, 6th annual CaPCure meeting, October 1999, Lake Tahoe, NV.
• "Interstitial saline augmented radiofrequency ablation of renal tumors: further evaluation of a new technology." Poster session, AUA 95th annual meeting, May 2000, Atlanta, GA.
• Demark-Wahnefried W, Price DT, Polascik TJ, Anderson EE, Robertson CN, Walther P, Paulson DF, Gannon M and Vollmer R: Effect of short-term flaxseed supplementation and fat modification in men with prostatic carcinoma. Cancer Epidemiol Biomarkers Prev 9:235, 2000.
• Demark-Wahnefried W, Price DT, Polascik TJ, Anderson EE, Robertson CN, Walther P, Paulson DF, Gannon M and Vollmer R: Short-term flaxseed supplementation and fat restriction in men with prostate cancer: Effects on Prostate-specific antigen (PSA), hormonal factors and proliferation rates. Abstract #3029. Proceedings of the American Association for Cancer Research, 41: 475, 2000.
• Demark-Wahnefried W, Price DT, Polascik TJ, Anderson EE, Robertson CN, Walther P, Paulson DF, Gannon M and Vollmer R: Presurgical fat restriction and flaxseed supplementation among men with prostate cancer: Effects on PSA, hormonal factors and proliferation rates. Abstract #1301, J Urol 163: 293, 2000.
• Demark-Wahnefried W, Price DT, Polascik TJ, Anderson EE, Robertson CN, Walther P, Paulson DF, Gannon M and Vollmer R: Fat restriction and flaxseed supplementation in men with prostate cancer: Effects on Prostate-specific antigen (PSA), hormonal and histopathological markers. J Amer Diet Assn 100:A-21, 2000.
• Demark-Wahnefried W, Price DT, Polascik TJ, Anderson EE, Walther P, Paulson DF, Gannon M and Vollmer R: Presurgical fat restriction and flaxseed supplementation among men with prostate cancer: Effects on PSA, hormonal factors and proliferation rates. J Nutrition (in press).
• "Hypertonic interstitial saline-augmented radiofrequency ablation of renal tumors: assessment of a new technology for laparoscopic or percutaneous application." 9th International Meeting of Laparoendoscopic Surgeons, SLS Annual meeting, ENDO EXPO 2000, Orlando, FL, Dec 2000.
• "Hand-assisted laparoscopic nephrectomy: Preliminary experience." 9th International Meeting of Laparoendoscopic Surgeons, SLS Annual meeting, ENDO EXPO 2000, Orlando, FL, Dec 2000.
• "Factors influencing return to employment following laparoscopic renal surgery." Southeastern AUA, New Orleans, May 2001.
• "Hand-assisted laparoscopic nephrectomy for the scarred kidney." Southeastern AUA, New Orleans, May 2001.
• "Utility of capromab pendetide imaging to detect recurrent disease after radical prostatectomy." Southeastern AUA, New Orleans, May 2001.
• Raj GV, Partin AW and Polascik TJ: "Utility of capromab pendetide to image early recurrent disease after radical prostatectomy." American Urological Association annual meeting, Anaheim CA June 2-7, 2001
• DeGrado TR, Wang S, Baldwin SW, Orr MD, Robertson CN, Polascik TJ, Kelley MJ, Liao R, Coleman RE and Price DT: "F-18 labeled choline analogs as PET imaging probes of prostate cancer." American Urological Association annual meeting, Anaheim CA June 2-7, 2001
• "Comparison of F-18 fluorocholine and FDG in PET imaging of androgen-dependent and androgen-independent prostate cancer." Academy of Molecular Imaging, Orlando FL October 24-28, 2001.
• "Use of bipolar laparoscopic forceps to occlude and transect the retroperitoneal vasculature: a porcine model." World Congress of Endourology, Bangkok, Thailand, November 2001.
• "Cryoablation parameters using swine renal tissue." World Congress of Endourology, Bangkok, Thailand, November 2001.
• "Effects of a low fat, flaxseed-supplemented diet on men with prostatic intraepithelial neoplasia (PIN) or atypia." AACR Frontiers in Cancer Prevention Research Conference, Boston, MA, October 14-18, 2002.
• "Does a prior negative prostate biopsy predict outcome for patients treated with radical perineal prostatectomy?" Society of Urologic Oncology, NIH, Bethesda MD December 13-14, 2002.
• "Renal cryosurgery: Worst case scenarios in a porcine model." Dept of Anesthesiology Eleventh Annual Academic Evening, Duke University, Durham Hilton, Durham, NC, May 6, 2003.
• "Renal radiofrequency ablation: Worst case scenarios in a porcine model." Dept of Anesthesiology Eleventh Annual Academic Evening, Duke University, Durham Hilton, Durham, NC, May 6, 2003.
• “Radiofrequency ablation: worst case scenarios in a porcine model” North Carolina Urologic Resident Seminar, Greensboro NC, November 8, 2003.
• Renal radiofrequency ablation: worst case scenarios in a porcine model. AARS 2004.
• “Renal radiofrequency ablation versus cryosurgery: Understanding short-term complications in a porcine model” Society of Urologic Oncology, NIH, Bethesda MD Dec 5, 2003.
• Renal cryosurgery: worst case scenarios in a porcine model. XIXth EUA Congress, Vienna Austria March 24-27, 2004.
• Renal radiofrequency ablation: worst case scenarios in a porcine model. XIXth EUA Congress, Vienna Austria March 24-27, 2004.
• Characteristics of patients with complications following percutaneous radiofrequency ablation of renal tumors. SEAUA 68th annual meeting March 24-27, 2004, Aruba.
• Renal radiofrequency ablation: worst case scenarios in a porcine model. SEAUA 68th annual meeting March 24-27, 2004, Aruba.
• Renal radiofrequency ablation: worst case scenarios in a porcine model. American Roentgen Ray Society, 104th annual meeting, May 2-7 2004 Miami Beach.
• Renal cryoablation and radiofrequency ablation: an evaluation of worst case scenarios in a porcine model. Presented at the Urology Residents and Fellows Forum of Excellence, AUA meeting May 13, 2004 San Francisco, CA.
• An open label trial of the effect of zoledronic acid on bone mineral density in hormone sensitive prostate cancer patients with bone metastases. AUA Western sectional meeting, August 2004.
• Characteristics of patients with complications following percutaneous radiofrequency ablation of renal tumors. Society of Urologic Oncology, NCI/NIH, December 3, 2004.
• Does a prior benign prostate biopsy predict outcome for patients undergoing a radical perineal prostatectomy? 2005 Multidisciplinary Prostate Cancer Symposium, ASCO, Orlando, FL, February 17-19, 2005.
• An open-label trial of the effect of zoledronic acid on bone mineral density in hormone-sensitive prostate cancer patients with bone metastasis. Podium session, Southeastern American Urological Assn annual sectional meeting, Charleston SC, March 6, 2005.
• Intentional cryosurgical injury of vital renal structures in a porcine model. Podium session, Southeastern American Urological Assn Annual Meeting, Charleston SC, March 5, 2005.
• Renal cryoablation and radiofrequency ablation: an evaluation of worst case scenarios in a porcine model. Podium session, American Urological Assn Annual Meeting, San Antonio TX, May 21-26, 2005.
• Characteristics of patients with complications following percutaneous radiofrequency ablation of renal tumors. Poster session, American Urological Assn Annual Meeting, San Antonio TX, May 21-26, 2005.

^ Back to top